Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines

Molecular Cancer Therapeutics
Joel GreshockTal Zaks

Abstract

A common aim of pharmacogenomic studies that use genome-wide assays on panels of cancers is the unbiased discovery of genomic alterations that are associated with clinical outcome and drug response. Previous studies of lapatinib, a selective dual-kinase inhibitor of epidermal growth factor receptor (EGFR) and HER2 tyrosine kinases, have shown predictable relationships between the activity of these target genes and response. Under the hypothesis that additional genes may play a role in drug sensitivity, a predictive model for lapatinib response was constructed from genome-wide DNA copy number data from 24 cancer cell lines. An optimal predictive model which consists of aberrations at nine distinct genetic loci, includes gains of HER2, EGFR, and loss of CDKN2A. This model achieved an area under the receiver operating characteristic curve of approximately 0.85 (80% confidence interval, 0.70-0.98; P < 0.01), and correctly classified the sensitivity status of 8 of 10 head and neck cancer cell lines. This study shows that biomarkers predictive for lapatinib sensitivity, including the previously described copy number gains of EGFR and HER2, can be discovered using novel genomic assays in an unbiased manner. Furthermore, these results ...Continue Reading

References

Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·F K LinZ Stabinsky
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Nov 1, 2001·Nature Genetics·A M SnijdersD G Albertson
Apr 17, 2002·Science·Howard M CannL Luca Cavalli-Sforza
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Christophe Ambroise, Geoffrey J McLachlan
Jun 28, 2002·Cancer Cell·Barbara L Weber
Jul 6, 2002·Science·I Bernard Weinstein
Feb 6, 2004·Genome Research·Graham R BignellRichard Wooster
Oct 12, 2004·Biostatistics·Adam B OlshenMichael Wigler
Feb 3, 2005·Nature Reviews. Cancer·Keith D HunterPaul R Harrison
Feb 19, 2005·Medical Immunology·Léa TourneurGilles Chiocchia
Mar 15, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Elizabeth PangNathalie Wong
May 3, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sarah L McDonaldAndrew C Schofield
Aug 23, 2005·Genes, Chromosomes & Cancer·Masamitsu SatoTakashi Kohno
Oct 6, 2005·Human Molecular Genetics·Guiqing HuangColin Collins
Nov 4, 2005·Bioinformatics·Nusrat Rabbee, Terence P Speed
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Dec 13, 2005·Cancer Genetics and Cytogenetics·Lovisa OsterbergGyörgy Horvath
Sep 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine H ChungFred R Hirsch
Oct 3, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Judy E AndersonMarek Los
Oct 24, 2006·Cell·William Y Kim, Norman E Sharpless
Oct 24, 2006·Nature Medicine·Anil PottiJoseph R Nevins
Dec 29, 2006·The New England Journal of Medicine·Hyman B Muss
Feb 3, 2007·International Journal of Cancer. Journal International Du Cancer·Peixiang LiNelly Auersperg
Oct 31, 2007·Cancer Research·Joel GreshockLynda Chin

❮ Previous
Next ❯

Citations

Sep 15, 2010·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hiroyuki AraiYuichiro Nishimura
Feb 12, 2009·Pharmacogenomics·David Gurwitz, Howard L McLeod
Feb 20, 2016·BMC Bioinformatics·Jared S FowlesDaniel L Gustafson
Mar 5, 2009·Cellular Signalling·Vladimir RatushnyJoshua S Silverman
Apr 21, 2009·Head & Neck·Jonathan B Cooper, Ezra Eddy Wyssam Cohen
Nov 15, 2014·Nature Communications·Josien C HaanGerrit A Meijer
Oct 27, 2017·Nature Communications·Zhaleh SafikhaniBenjamin Haibe-Kains
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Helen J RossFrances A Shepherd

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

The New England Journal of Medicine
Charles E GeyerDavid Cameron
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Fred R HirschWilbur A Franklin
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
María J PajaresLuis M Montuenga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nancy U LinEric P Winer
© 2022 Meta ULC. All rights reserved